June 1, 2012
1:12-cv-00703
35:271 Patent Infringement
News Coverage, Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Abbott Laboratories on Friday continued its crusade to protect its cholesterol drug Niaspan by filing a lawsuit against Kremers Urban Pharmaceuticals Inc., accusing the company of infringing Abbott's patents through its efforts to market a generic version of the drug.